Jade Biosciences (JBIO) Competitors $11.14 +0.34 (+3.15%) As of 07/3/2025 01:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsSEC FilingsTrendsBuy This Stock JBIO vs. KZR, OKUR, BDRX, RNTX, KALA, EGRX, MRNS, EYEN, DYAI, and ALLKShould you be buying Jade Biosciences stock or one of its competitors? The main competitors of Jade Biosciences include Kezar Life Sciences (KZR), OnKure Therapeutics (OKUR), Biodexa Pharmaceuticals (BDRX), Rein Therapeutics (RNTX), KALA BIO (KALA), Eagle Pharmaceuticals (EGRX), Marinus Pharmaceuticals (MRNS), Eyenovia (EYEN), Dyadic International (DYAI), and Allakos (ALLK). These companies are all part of the "pharmaceutical products" industry. Jade Biosciences vs. Its Competitors Kezar Life Sciences OnKure Therapeutics Biodexa Pharmaceuticals Rein Therapeutics KALA BIO Eagle Pharmaceuticals Marinus Pharmaceuticals Eyenovia Dyadic International Allakos Jade Biosciences (NASDAQ:JBIO) and Kezar Life Sciences (NASDAQ:KZR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings. Which has better valuation and earnings, JBIO or KZR? Kezar Life Sciences is trading at a lower price-to-earnings ratio than Jade Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJade BiosciencesN/AN/A-$69.63M-$59.65-0.19Kezar Life SciencesN/AN/A-$83.74M-$10.82-0.42 Which has more risk and volatility, JBIO or KZR? Jade Biosciences has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. Comparatively, Kezar Life Sciences has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Do analysts prefer JBIO or KZR? Jade Biosciences currently has a consensus price target of $14.00, indicating a potential upside of 25.67%. Kezar Life Sciences has a consensus price target of $39.50, indicating a potential upside of 766.23%. Given Kezar Life Sciences' higher possible upside, analysts clearly believe Kezar Life Sciences is more favorable than Jade Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jade Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Kezar Life Sciences 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media favor JBIO or KZR? In the previous week, Jade Biosciences had 2 more articles in the media than Kezar Life Sciences. MarketBeat recorded 5 mentions for Jade Biosciences and 3 mentions for Kezar Life Sciences. Jade Biosciences' average media sentiment score of 0.54 beat Kezar Life Sciences' score of -0.67 indicating that Jade Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jade Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kezar Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Is JBIO or KZR more profitable? Jade Biosciences' return on equity of -60.01% beat Kezar Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Jade BiosciencesN/A -60.01% -54.32% Kezar Life Sciences N/A -61.15%-50.27% Do institutionals & insiders have more ownership in JBIO or KZR? 67.9% of Kezar Life Sciences shares are owned by institutional investors. 24.9% of Jade Biosciences shares are owned by company insiders. Comparatively, 10.4% of Kezar Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryJade Biosciences beats Kezar Life Sciences on 8 of the 12 factors compared between the two stocks. Get Jade Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for JBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JBIO vs. The Competition Export to ExcelMetricJade BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.36M$2.91B$5.56B$9.04BDividend YieldN/A2.44%5.22%3.99%P/E Ratio-0.1921.5627.6620.25Price / SalesN/A283.36423.00177.43Price / CashN/A42.7336.8958.10Price / Book0.127.518.035.67Net Income-$69.63M-$55.14M$3.18B$249.21M7 Day Performance21.22%4.61%2.93%3.28%1 Month PerformanceN/A0.90%1.72%3.95%1 Year PerformanceN/A5.40%34.39%20.98% Jade Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JBIOJade Biosciences2.7075 of 5 stars$11.14+3.1%$14.00+25.7%N/A$9.36MN/A-0.1920News CoverageKZRKezar Life Sciences4.1966 of 5 stars$4.40-3.9%$39.50+797.7%-21.4%$33.46M$7M0.0060OKUROnKure Therapeutics2.6828 of 5 stars$2.40+0.4%$32.33+1,247.2%N/A$32.29MN/A0.00N/ABDRXBiodexa Pharmaceuticals0.6978 of 5 stars$0.87+0.6%N/AN/A$31.61M$470K0.0020Positive NewsUpcoming EarningsRNTXRein TherapeuticsN/A$1.45+3.6%N/AN/A$31.01MN/A0.009KALAKALA BIO3.3781 of 5 stars$4.84+1.7%$13.50+178.9%-23.3%$30.71M$3.89M0.0030High Trading VolumeEGRXEagle PharmaceuticalsN/A$2.36-18.6%N/A-45.5%$30.65M$257.55M0.00100Gap DownMRNSMarinus Pharmaceuticals2.3379 of 5 stars$0.55-0.2%$3.92+613.3%-54.2%$30.32M$30.99M-0.22110News CoverageEYENEyenovia2.6256 of 5 stars$10.56+1.7%$2.00-81.1%-77.1%$29.92M$60K0.0040Analyst UpgradeDYAIDyadic International2.004 of 5 stars$0.97-2.0%$6.00+518.6%-35.3%$29.79M$3.49M0.007News CoverageGap UpALLKAllakos2.8748 of 5 stars$0.33flat$2.00+507.7%N/A$29.74MN/A-0.16190 Related Companies and Tools Related Companies Kezar Life Sciences Competitors OnKure Therapeutics Competitors Biodexa Pharmaceuticals Competitors Rein Therapeutics Competitors KALA BIO Competitors Eagle Pharmaceuticals Competitors Marinus Pharmaceuticals Competitors Eyenovia Competitors Dyadic International Competitors Allakos Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JBIO) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredJuly 4th: 59% dividend from Bitcoin (No Crypto Needed)I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Y...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jade Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jade Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
